<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Suggested management of neuromuscular blockade according to monitoring</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Suggested management of neuromuscular blockade according to monitoring</h1>
<div class="graphic"><div class="figure"><div class="ttl">Suggested management of neuromuscular blockade according to monitoring</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">Modality/response*</td> <td class="subtitle1">Interpretation/management</td> <td class="subtitle1">Comments</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Intubating conditions</td> </tr> <tr> <td class="indent1"> <p>TOFC 0</p> TOFR 0</td> <td>Adequate conditions likely</td> <td>During onset of neuromuscular block, diaphragm and vocal cords become paralyzed prior to the adductor pollicis muscle. Diaphragm and vocal cords also recover prior to adductor pollicis.</td> </tr> <tr> <td class="indent1"> <p>TOFC ≥1</p> TOFR ≥0</td> <td>Adequate conditions unlikely</td> <td>Profound block is required for optimal intubating conditions.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Intraoperative conditions</td> </tr> <tr> <td class="indent1">TOFC 0, PTC 1 to 5</td> <td>Deep blockade; return of diaphragm movements possible, twitch may return in 5 to 15 minutes, may have twitch response at face with PNS</td> <td> </td> </tr> <tr> <td class="indent1">TOFC 1 to 3</td> <td>Moderate blockade; sufficient for most procedures</td> <td>Deeper levels of block may be warranted in specific settings in which any unexpected movement must be avoided (eg, during delicate dissection under the microscope during craniotomy).</td> </tr> <tr> <td class="indent1">TOFC 4 ± fade</td> <td>Shallow or minimal block; additional NMBA may be needed</td> <td> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Management of recovery and reversal*</td> </tr> <tr> <td class="indent1">TOFC 0, PTC 0</td> <td>Complete or profound blockade; wait or administer sugammadex 16 mg/kg IV</td> <td rowspan="7"> <ul> <li>Sugammadex can be used to reverse only rocuronium or vecuronium.</li> <li>Neostigmine can be used to reverse any nondepolarizing NMBA.</li> <li>Neostigmine should only be used if the TOFC is 4.</li> </ul> </td> </tr> <tr> <td class="indent1">TOFC 0, PTC 1 or 2</td> <td>Deep blockade; wait or administer sugammadex 4 mg/kg IV</td> </tr> <tr> <td class="indent1">TOFC 1</td> <td>Moderate blockade; wait or administer sugammadex 4 mg/kg IV</td> </tr> <tr> <td class="indent1">TOFC 2 or 3</td> <td>Moderate blockade; wait or administer sugammadex 2 mg/kg IV</td> </tr> <tr> <td class="indent1"> <p>TOFC 4 with fade</p> TOFR &lt;0.4</td> <td>Shallow blockade; wait or sugammadex 2 mg/kg IV or neostigmine 20 to 50 mcg/kg IV</td> </tr> <tr> <td class="indent1"> <p>TOFC 4 without fade</p> TOFR 0.4 to 0.9</td> <td>Minimal blockade; wait or sugammadex 2 mg/kg IV or neostigmine 15 to 30 mcg/kg IV</td> </tr> <tr> <td class="indent1">TOFR ≥0.9</td> <td>Fully reversed; no need to administer reversal prior to extubation</td> </tr> </tbody></table></div><div class="graphic_lgnd">This table shows management according to qualitative and/or quantitative neuromuscular monitoring. Qualitative (subjective) monitoring refers to visual or tactile assessment of adduction of the thumb in response to ulnar nerve stimulation and the resulting contraction of the adductor pollicis muscle. Quantitative (objective) monitors measure the response of the muscle to neurostimulation and provide a ratio of the fourth to the first twitch in the train of four stimuli. Quantitative monitors should be used whenever they are available. For further information, refer to UpToDate content on the clinical use of NMBAs and monitoring neuromuscular blockade.</div><div class="graphic_footnotes"><p>TOFC: train of four count; TOFR: train of four ratio; NMBA: neuromuscular blocking agent; PTC: post tetanic count; PNS: peripheral nerve stimulator.</p>
* Train of four stimulation consists of four successive supramaximal stimuli using a peripheral nerve stimulator. After administration of a full dose of nondepolarizing NMBA, responses show fade, or progressively decreasing amplitude of the responses; with increasing block the number of responses to a train of four stimuli decreases. When the train of four count is zero, further information on the depth of block can be obtained by applying tetanic stimulation, followed by a series of single twitches for 20 seconds. The post tetanic count (PTC) refers to the number of twitches apparent in this series; increasing PTC correlates with less profound block.</div><div id="graphicVersion">Graphic 114082 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
